Should FDA cut out the time-consuming legal review of draft warning letters in order to expedite their delivery to pharma companies?
Yes
75%
No
25%
Subscribe
Print Magazine
Pharmaceutical Executive Magazine | Monthly Welcome to the online companion to Pharmaceutical Executive magazine. When pharmaceutical decision makers need news and insights about pharma’s future and how to respond to it, they turn to Pharmaceutical Executive magazine. From strategy to marketing to the best new ideas about sales, R&D, regulations, finance, meetings and IT, Pharmaceutical Executive covers it all. Subscribe